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a b s t r a c t
MV repair in the rheumatic population is feasible with acceptable long-term results.1
Incidence of mitral stenosis (MS) following mitral valve (MV) repair for severe rheumatic
mitral regurgitation (MR) and usefulness of percutaneous transluminal mitral valvuloplasty
(PTMC) in these patients is not described in literature.We report a case of successful PTMC in
severe MS following MV repair for severe rheumatic MR.
# 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).PTMCMitral valvuloplasty1. Case report19-year-old male, a known case of rheumatic heart disease for
7 years was diagnosed to have severemitral regurgitation (MR)
in 2008, when he was 12 years old. Patient had NYHA class III
symptoms; hencehewas taken forMV surgery. Intra-operative
ﬁndings were suggestive of rheumatic etiology. He underwent
mitral valve (MV) repair using indigenous annuloplasty ring
with a geometrical area of 3.6 cm2, which is equivalent to a
24 mm commercial ring and posterobasal chordal release.
Post-operative echocardiography revealed grade I MR and no
evidence of MS with MVmean gradient of 3 mmHg, MV oriﬁce
area (MVOA) of 2.6 cm2.
In May 2015, after 7 years of MV repair, patient presented
withhistory of extertional dyspnea and fatigue of threemonths* Corresponding author.
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Echocardiography revealed commissural fusion with MVOA of
0.8 cm2, mild MR and no signiﬁcant subvalvar pathology or
calciﬁcation of thevalve (Figs. 1 and 2). In viewof younger age of
patient, poor physical growth and suitable morphology of MV
for percutaneous transluminal mitral valvuloplasty (PTMC)
with Boston score (Wilkins score) of 6, he was considered for
PTMC. Samewasdiscussedwith thoracic surgeons.Heart teams
opinion was to attempt PTMC so that MV replacement (MVR)
may be delayed for few more years.
Through right femoral vein approach patient underwent
PTMCwith 26 mmAccura balloon inﬂated to 23 mm (Figs. 5–8).
Procedure was successful with single inﬂation. Medial com-
missure was split and lateral commissure was partially split.
MVOA increased from 0.8 to 1.65 cm2, MV gradient decreased
from 24/15 to 14/7 mmHg, mean left atrial pressure (LAP)B.V. This is an open access article under the CC BY-NC-ND license
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Fig. 1 – Pre-PTMC echo showing restricted mobility of mitral
leaflets.
[(Fig._2)TD$FIG]
Fig. 2 – Pre-PTMC echo showing severe MS with MVOA-
0.827 cm2.
[(Fig._3)TD$FIG]
Fig. 3 – Showing good leaflet movement following
successful PTMC.
[(Fig._4)TD$FIG]
Fig. 4 – Showing MVOA of 1.65 cm2 following PTMC.
Table 1 – Showing comparison of echocardiography and
hemodynamic parameters before PTMC and after PTMC.
Pre-PTMC Post-PTMC
Mean LAP (mmHg) 26 14
Right ventricular
systolic pressure
58 42
i n d i a n h e a r t j o u r na l 6 8 ( 2 0 1 6 ) s 8 – s 1 0 S9decreased from 26 to 14 mmHg (Figs. 3 and 4, Table 1). There
was signiﬁcant reduction in PASP from 58 to 42 mmHg. There
was no increase in MR. Procedure was uneventful.
2. Discussion
(mmHg)
MVOA (cm2) 0.8 1.65
MV Gradient
(mmHg)
24/15 14/7
Commissures Both fused Medial split,
lateral partially
split
MR Grade I Grade IMV repair in rheumatic patients, using current techniques, can
effectively correct hemodynamic and functional abnormali-
ties with satisfactory results.2
In a study by Choudhary et al.2 718 patients with rheumatic
severe MR underwent MV repair and three patients (0.4%)
developed signiﬁcant MS and all underwent reoperation.
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Fig. 6 – Fluoroscopic picture post-septal puncture showing
mullin sheath in LA.
[(Fig._8)TD$FIG]
Fig. 8 – Fluoroscopic picture showing inflation of accura
balloon across MV.
[(Fig._5)TD$FIG]
Fig. 5 – Fluoroscopic picture pre-septal puncture showing
mitral annuloplasty ring.
[(Fig._7)TD$FIG]
Fig. 7 – Fluoroscopic picture showing coiled guide wire in LA.
i n d i a n h e a r t j o u rn a l 6 8 ( 2 0 1 6 ) s 8 – s 1 0S10PTMC is the procedure of choice for the treatment of MS;
surgical intervention is now reserved for patients, who are not
candidates for a percutaneous procedure.3
Incidence of MS following MV repair for rheumatic MR is
not known. There are no data available regarding treatment
plan for these patients. To the best of our knowledge
usefulness of PTMC for MS following MV repair for rheumatic
MR is not available in the literature.
Hence we share our experience of feasibility and safety of
PTMC in MS following MV repair for severe rheumatic MR.
3. ConclusionIn patients with suitable valve morphology PTMC can be done
successfully in MS following MV repair for severe rheumatic
MR. This may help to delay the need for MVR in younger
patients.
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